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ABSTRACT
The commercial application of imidazolinone derivatives can be found in
herbicides where they inhibit acetolactate synthase (ALS; EC 4.1.3.18; also known as
acetohydroxyacid synthase). The imidazolinone class ofherbicides have the
advantage of long term activity and low mammalian toxicity. Another application of
imidazolinone derivatives is in the preparation of a-alkyl-amino acids.
The objective of this investigation was to explore the asymmetric synthesis of
imidazolinones through the condensation of a variety of imidate ethyl esters and
cc-
amino acids. Furthermore, it was of interest to characterize the chiral properties of a
series of imidazolinone derivatives for future investigation. In this research project,
the method of synthesis of imidazolinones was applied and modified from the method
which was established in the work ofKidwai, A. Q. and Devasia. G. M. in 1962. (J.
Org. Chem. 1962, 27, 4527) Their synthetic work was only successful with aromatic
amino acids and benzimidates, therefore, an attempt was made to generalize the




The five-member-heterocyclic compounds which contain two nitrogen atoms
can be classified into two main categories as imdazole and pyrazole families, as
shown in Table 1-1. The general rule ofnumbering of this ring system usually starts

























1 NH 1 N
Imidazolindine Imidazoline Pyrazolidine Pyrazoline
Table 1-1 IUPAC rules for five-member-heterocyclic compounds which contain two
nitrogen atoms
In my research, the imidazolinone ring system amember of the imidazole
family is the object ofmy studies.(Fig.l-l) There are many research reports about
this ring system especially in the applications ofherbicides and as precursors to






Fig. 1-1 The nomenclature of imidazolinone.
The compound shown in this figure
is called Imidazolin-5-one.
In addition to imidazolinone, the closest family that has the fully saturated
ring system is called imidazolindinone (Fig. 1-2). The imidazolindinone compounds












Fig 1-2 The structure of imidazolidinone.
An interesting application of imidazolindinones is to serve as a prodrug. The
term
"prodrugs"
means that the chemical drug form needs to be metabolized in the
body in order to get a bioactive drug form. Since hydrophilic compounds do not
easily penetrate the cell membrane when they exert their biological effect, converting
these hydrophilic compounds to lipophilic compounds is one of the solutions. The
imidazolindinone ring system is easily synthesized from an a-aminoamide when
reacted with acetone (Scheme 1-1). This ring system can also be hydrolysed under
some certain physiological conditions such as pH and temperature. Thus this ring
compound can act as a prodrug to carry drug which has an a-aminoamide or peptide
moiety.3,4
The study ofKlixbull, et. al., (1984) has shown the supported kinetic
hydrolysis data in physiological conditions for these 4-imidazolidinones bioreversible








Another interesting study of the derivatives of imidazolidinone ring
investigates their use as antioxidants and free radical scavengers. Compounds called
reactive oxygen species (ROS), summarized in Table 1-2, can be generated by
electron transfer or energy
transfer.6
ROS are harmful to the body, causing problems
such as ischemia and inflammations as well as diseases such as cancer;
neurdegenerative diseases such as Parkinson's disease, and Alzheimer dementia.
There are two ways to treat the ROS induced diseases: one is by inhibiting
their formation and the other by scavenging the ROS. Several synthetic antioxidants
such as allopurinol, dimethylurea, and sulfur containing endogenous thiooctic acid
were efficient in neuronal
damage.7' 8
Reactive oxygen species HalfLife (s)
02 | oxygen stable




| superoxide anion radical stable
or ;
peroxide stable




Q ! semiquinone radical days
RO ] alkoxide radical
IO"6
NO* | nitric oxide radical 1-10
ON02"
| peroxynitrite 0.05-1
Table 1-2 Reactive oxygen species and their half life
The sulfhydryl groups of amino acids such as glutathione have been suggested
to have an antioxidant defense
mechanism.9
In a recent report (1996), it was shown





















Scheme 1-2 The synthesis of the mercaptoalkyl derivatives of 5,5-diphenyl-
hydantoin
1.2. Tautomerism
There are three tautomers in the family of imidazolinones. If the N-l






Scheme 1-3 Tautomerism of imidazolinone (I)
The imidazolin-4-one is believed to be more stabile than 5 -one because of the
conjugated a, P-unsaturated carbonyl structure. One supportive evidence was shown
from the X-ray crystal structure of 5-benzyl-5-hydroxy-2-phenyl-imidazolin-4-one
(Fig. 1-3), the intermediate of the alkaline hydrolysis of
4-benzyl-2-phenyl-
imidazolin-4-one."







Fig. 1-3 5-benzyl-5-hydroxy-2-phenyl-imidazolin-4-one with atom numbering.
Besides these two tautomers, a C-4 (5) hydrogen shift from each of
these
structures generates two tautomeric enol structures which are aromatic (Scheme 1-4).
In the structure of the hydroxyimidazoles, the p-electrons of the
sp3
nitrogen are
parallel to the 7t-system which is pyrole-like and contributes its electrons to make this
6 Huckel system. Thus the stability of aromaticity of this structure can be
determined by the 4n+2
rule.12
If there is no proton in the C-4 position, the tautomers






























Scheme 1-4 Tautomerism of imidazolinone (II)
The stable imidazolin-4 (5)-one may be predominantly exist as the
5-
hydroxyimidazole under some favorable conditions such as the presence of an
aromatic substituent at C-2. An example is illustrated in Scheme 1-5.
13
This enolic
form is the more stable tautomer and the enolic anion has been shown to act as an















1.3. The Application of Imidazolinone Compounds
1.3.1. Imidazolinones as Herbicides
There are over 30 different classes ofherbicides which are currently
commercially available. Their activation can be categorized by eight different plant
physiological sites which are listed in Table 1-3.
'4
Among the herbicides, the
sulfonylureas, imidazolinones, and triazolopyrimidine sulfonanilides are known to
inhibit the activity of acetolactate synthase (ALS, EC 4.1.3.18, also known as
acetohydroxyacid synthase). Another class ofherbicide called pyrimidinyl
oxybenzoates is known to act as inhibitor ofALS, but has not been
commercialized.15
Acetolactate synthase (ALS) is an important enzyme in the amino acid
synthesis pathway to produce leucine, isoleucine, and valine in plants and
microorganisms. The major function ofALS is to catalyze the following two
reactions:
1. condensation of two pyruvates to generate C02 and a- acetolactate which is a
precursor of valine and leucine;
2. condensation ofpyruvate and ct-ketobutyrate to generate C02 and 2-
acetohydroxybutyrate which is a precursor of isoleucine.
All of these three amino acids are important for protein synthesis in the root tip region
of the plant.
16' l7
The mechanisms of the actions of sulfonylureas and imidazolinones
are summarized in Scheme
1-6.18
Herbicides belonging to the sulfonylureas and
imidazolinones classes act as slow-binding inhibitors. Death of the whole plant
occurs within a few
weeks.19
The advantage of an imidazolinone herbicide is its long
term activity and low mammalian
toxicity.20
Physiological action site Molecular sites Herbicide families














Bleaching Photosystem I Bipyridyliums
Heteropentalenes
Protoporphyrinogen oxidase Diphenyl ethers
Oxadiazoles
N-phenyl imides
Lipid synthesis Acetyl CoA carboxylase Aryloxyphenoxy propionates
Cyclohexanediones






IPP isomerase / phenyl transferase Isoxazolidinones
Cell division P-Tubulin Dinitroanilines
Phosphoric amides
Cellulose synthesis unknown Dichlobenil
Folate synthesis Dihydropteroate synthase Asulam








































































































Scheme. 1-6 The inhibition by sulfonylurea and imidazolinone herbicides on the ALS pathway.
11
The bioactive structure of an imidazolinone (Fig 1-4) herbicide requires a methyl
and isopropyl substituent attached to the adjacent nitrogen atom and carbonyl group of
the imidazolinone ring
system.21
This imidazolinone ring is attached to an aromatic ring
which has a carboxylic acid group substituted in a nearby position. The aromatic ring
system is usually a benzyl or pyridine group. Recent research data suggested that
substitution in the 5-position with electron-donating group of the pyridine ring had





Fig 1-4 The general structure of imidazolinone herbicides
Discovery of imidazolinones as herbicides started in 1971 when the
phthalimide (I) was first investigated as a potential anticonvulsant ( Scheme
1-7).23
When phthalimide was first tested as herbicide, it was successful during primary
screening. Further investigation led to synthesis of chlorophthalimide AC 94,377 (II),
a plant growth stimulant. A cyclic analog (III) of chlorophthalimide (II) was found
to be more efficient as an herbicide than (I). The investigation of compound (III) led
to the synthesis of imidazolinylbenzoate (IV) which is a good but non-selective
12
herbicide. Significant improvement was made on the activity of these compounds by
replacing the benzoic acid with nicotinic acid (V). This resulted led to commercial

























Scheme 1-7 The development of an imidazolinone herbicide.
14






























Reference: Pestic. Sci. 1990, 39, p. 294
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1.3.2. Imidazolinones as Precursor of a-Amino Acids
In addition to herbicides, imidazolinones are useful as precursors for the
preparation ofnew asymmetric amino acids. In 1975, Davasia and Rajasekharan had
reported a one-step reaction in converting unsaturated imidazolinones to acylamino
acids by reaction with zinc dust and refluxing 14 % potassiun hydroxide (Scheme 1-
8).
24













Scheme 1-8 Conversion of imidazolinones to acylamino acids (I)
This one-step conversion is an improvement over the two-step reaction where
the unsaturated 2,4-disubstituted imidazolinones are converted to the corresponding





R,^CV^ H2 ^V^C l%NaOH
T1
1 N *" R2 I N R2CHCHCOOH + NH3
HN^ PdorPt HN^ reflux I
^ ^ NHCOR3
R3 R3
Scheme 1-9 Conversion of imidazolinones to acylamino acids (II)
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The asymmertric synthesis of cc-alkyl-a-aminocarboxylic acid from alkylation
of a chiral substituted imidazolin-5-one was reported by Schollkopf, et. al., in
1978.25
In their study, the methyl 2-isocyanoalkanoate was first condensed with (S)-l-
phenylethylamine to form (S)-N-phenyl ethyl-2-isocyanoalkanamide. then followed
by base-induced cyclization to leading to the 4-metalated imidazolinone. The
metalated imidazolinone was in equilibrium with its enolic form which can readily
react with alkyl halide to form a 4,4-disubstituted imidazolinone. The 4,4-
disubstituted imidazolinone can be hydrolyzed either under acid or alkaline
conditions to generate an a-alkyl-a-aminocarboxylic acid.
ch3 . .
CN H2N-CH^ \ CN NC
CH3-CH-C02CH3 ? . CH3-CH-CONH-L*
M'base
CH3-C-CONH-L*
12 h at room temperature, -60C I
L*
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Scheme 1-10 The Synthesis of a-alkyl-a-aminocarboxylic acid
17
Another interesting method of converting imidazolinones to amino acids by
enzymes is found in the histidine to glutamate degradation
pathway.26
(see Scheme 1-
1 1) In this scheme, the NH3 group is eliminated from histidine by histidase followed
by urocanase to form 4-imidazolone-5 -propionate which has an imidazolinone ring.
The imidazolinone ring is then hydrolyzed to form N-formiminoglutamate. The
N-
formiminoglutamate is then converted to glutamate by transfer of the formimino
group to tetrahydrofolate
(FH4).27
An interesting aspect of this conversion is the hydrolysis of the imidazolinone
ring by an enzyme instead of a nonbiological chemical processes. Thus, the potential






































Scheme 1-11 Conversion ofHistidine to Glutamate
19
1.3.3. Imidazolinone as a Chiral Chelating Ligand
It was reported that histidine can act as an important bidentate chelating
agent.28
Several research papers describe the use of the a-amino acids as a chiral
ligands.29
My original idea for imidazolinone as a chiral ligand is inspired by the heme
group ofmyoglobin. The two histidines ofmyoglobin are located at F8 and E7 which












Fig. 1-5 Schematic diagram of the binding site ofmyoglobin
The histidine imidazolinone adduct shown in Fig. 1-6 has great potential as a
chiral chelate ligand. The nitrogen at the 3 position of the imidazoline ring can
coordinate with the nitrogen at 3 position in histidine. Since the imidazolinone has a
chiral center which may have a specific orientation,
this trait may be developed in the
function of chelating effect of this ring
system in a future study.
20
Fig. 1-6 The imidazolinone product from histidine and imidate ethyl ester as a
potential chelate ligand.
21
1.4. Synthesis of Imidazolinones
1.4.1. From Amidine or Imidic Acid Ethyl Esters
30
The first representative of this class of imidazolinone was obtained by
Ruhemann and Cunninghton in
1899.31
The reaction of ethyl phenylpropiolate and


















Scheme 1-12 The first synthesis of imidazolinone in 1899
The similar reaction pathway also can be done by condensation of amidines





















can be aromatic or aliphatic
Scheme 1-13 The synthesis of imidazolinone from amidines and a-amino acids
22
It has been reported (Diel, et. al.) as early as 1916 that benzamidine
hydrochloride reacted with biacetyl in aqueous solution in the presence of sodium
acetate gives the 2-phenyl-4,5-dihydroxy-dimethyl-imidazole.34
This adduct rapidly
dehydrates when heated with hydrochloric acid. If the monohydroxyimidazole
undergoes further oxidation, the 2-phenyl-5-methyl-4-hydroxymethyliminazole is























Scheme 1-14 The synthesis of2-phenyl-5-methyl-4-hydroxymethyliminazole
In 1948, Cornforth and Huang reinvestigated the study of the condensation of
benzamidine with a-diketones, previously studied by Diel, et. al., in
1916.35
They
also studied the reaction ofbenzamidine hydrochloride with methylglyoxal in order to
synthesized the analogues ofhistidine. Their study was not successful because
imidazolinone products formed instead ofhydroxymethyliminazole.
23
In 1962, Ginsburg had reported the synthesis ofN-substituted imidazolinones
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Scheme 1-15 The synthesis ofN-substituted imidazolinone
In addition, Kidwai (1962) has reported the synthesis of 2-phenyl-4-benzyl-2-

















Scheme 1-16 The imidazolinone from the condensation ofbenzimidic acid ester with
phenylalanine ester
24
The mechanism of the condensation reaction of an imidate and amino acid













Scheme 1-17 The mechanism of imidazolinone formation
The synthesis of imidazolinone rings was further investigated by the




by Devasia, et. al., was carried out by condensing an aromatic aldehyde with a
mixture of iodoacetic ester and aromatic amidine hydrochloride in the presence of
sodium hydrogen carbonate (Scheme 1-18) In this study, the method which used
ethyl bromoacetate had a higher yield than that using ethyl chloroacetate. They found
that the imidazolinone ring was formed more quickly in the former method due to the
higher reactivity of ethyl bromoacetate compared to ethyl chloroacetate. To confirm
this conclusion of reactivity, the ethyl iodoacetate was also used in this reaction.
From the experimental data, it was found that ethyl iodoacetate gave a better yield





















In 1990, Prager, et. al., reported the synthesis of
alkylbenzylidene-
imidazolinones from condensation of ethyl 3-phenylepoxybutanoate and guanidine
followed by cyclization to benzylideneimidazole with acetic anhydride. The















Scheme 1-19 The synthesis of alkylbenzylideneimidazolinone
27
1.4.2. From Amino Acid and O-dicarboxylic Acid (Herbicides)
Phthalic anhydride was reacted with a series of amino acids to give amide
intermediate I via pathway A or B (Scheme 1-20). The amide intermediate I upon
sodium hydride catalysis, gave imidazoisoindol-2,5-dione (II). The
imidazoisoindol-
2,5-dione (II) was then hydrolyzed to give imazapyr (III). Several other






























Scheme 1-20 Synthesis of imazapyr
28
1.4.3. The Other Interesting Pathway in Histidine Degradation
The imidazolinone ring can also can be generated by enzymes which are
known in the histidine degradation pathway (also see Scheme 1-11 at Section 1.3.2,














1.4.4. Preparation ofChiral Imidazolinones
The synthesis of imidazolinone derivatives in this research project was
accomplished using the method Kidwai et.
al.,36
in which imidate ethyl esters were
condensed with a-amino acid esters. The imidate esters were prepared from the
corresponding nitrile in anhydrous ethanol, using acid catalysis. The amino acids
used were all L-a-amino acid esters, which were commercially available as their
hydrochloride salts.
The objective of this research is to explore the potential pathway to synthesize
the imidazolinone ring system through condensation of chiral amino acids and
imidate ethyl esters. The unique aspect of our approach is to treat the pure chiral
materials, L-a-amino acids, with an imidate ester to generate an imidazolinone
product ofhigh enantiomeric excess. Subsequently, this imidazolinone product can
be subjected to further reactions to generate new chiral amino acids that may be
bioactive drug forms or their precursors.
The design of this experimental work can be separated into two stages: the
first stage is to synthesize a series of imidate ethyl esters as starting materials; the
second step is to use these
synthesized imidate ethyl esters to react with a variety of
a-amino acids to generate different imidazolinone products. The aim of this study is
also to compare the reactivity between
aromatic and aliphatic compounds.
30
Secondly, the chiral purity of the synthesized imidazolinone compounds will
be determined by chiral HPLC.
31
DISCUSSION OF RESULTS
The synthesis of imidate ethyl esters using acid catalysis was first discovered




R-C=N + R'OH ,
R-COR
Scheme 2-1 The Pinner synthesis
The synthesis of imidate ethyl ester also can be done under base-catalyzed
conditions. This reaction was first discovered by Nef in 1895 who reported the
reaction of cyanogen with ethanol in an aqueous solution ofpotassium
cyanide.44
In
the early 1900's, Stieglitz, et. al., and Marshall, et. al., had a more detailed study of
this base-catalyzed reaction (Scheme 2-2).
45,46
A similar study has also been done by








Scheme 2-2 Base-catalyzed reaction of Imidates
32
In my research, the acid catalyzed reaction was used in preparation of an
imidate ethyl ester. The nitrile was mixed with anhydrous ethyl alcohol, and the
mixture was cooled down to low temperature (0 C) while HC1 gas was bubbled into
the
reaction.48
The product gradually precipitated and was collected by suction
filtration after two days of reaction.

















Several synthetic methods for the synthesis of imidazolinone derivatives were
shown in previous discussion. The synthesis of2-phenyl-4-benzyl-2-imidazolin-5-
one had been done by Kidwai and Devasia in 1962 and was reported in
literature.36
Their method was to mix the phenylalanine ethyl ester and benzimidic ethyl ester at
33
room temperature. The mixture became solidified and was washed with dimethyl
ether.
In my research, this method is adapted and expended to include three different
imidate ethyl esters as mentioned before and five different amino acids: are histidine,
tryptophan, valine, proline and serine.






























































The mechanism of the condensation of imidate esters and a-amino acid esters
below, was shown previously in Scheme 1-16:
CH2C6H5











Reaction conditions must be carefully chosen such that the free base of each reactant
is formed without racemizing the chiral center of the amino acid ester. As result,
several experimental conditions were used for these condensation reactions.
Method A: Basification with aqueous sodium hydroxide; neat reaction conditions
The two reactants were again separately basified with 3N sodium hydroxide and
extracted following Method A. Subsequently the solvent was removed to give a neat
mixture of reactants that was allowed to react until a product precipitated.
Method B: Basification with aqueous sodium hydroxide; refluxed in methylene
chloride
The two reactants were separately basified with 3N sodium hydroxide, followed by
extraction of the neutral substrates with methylene chloride. The organic extracts
were then combined and the condensation allowed to proceed under neutral-slightly
basic conditions.
36
Method C: Basification with an organic base in THF
The two reactants were dissolved in a suitable organic solvent followed by
basification with an organic base such as pyridine, ethylamine or diethylamine.
37
2.1. Synthesis of imidate ethyl esters
All imidate ester were synthesized from the corresponding nitrile in anhydrous
ethanol, using gaseous hydrochloric acid as a catalyst. The imidate ester was then
expected to solidify in the reaction mixture as the hydrochloride salt which could then
be filtered, washed and dried.
NBHC1
R,COCH2CH3
Fig. 2-1 General structure of imidate ester
Methylimidate Ester (R,
= CH3-)
The white solid residue was formed as soon as the HC1 gas was added.
However, extend the reaction time to two days did not increase the yield of
methylimidate ester. The melting point was found 1 52 C, and yield was 20%.
Ethylimidate Ester (R,
= CH3CH2-)
The reaction was extended to three days. However, the prolonged reaction
time did not increase the yield. The yield was only 15%. The melting point was





The white solid suspension was sparse, the reaction was continued to seven
days. However, the prolong reaction time did not increase the yield. The yield was
only 13 %. The melting point was found vaporized after 340 C.
Benzylimidate Ester (R,
= C6H5-)
The reactants was gradually solidified and it was completely became a cake
after one day. The yield was recovered in 89%.
In these imidate esters preparation, the methylimidate ester was so reactive
with base that it was not able for the imidazolinone derivative reaction. Therefore,
there were only three different imidate esters, benzylimidate ester, isopropylimidate
ester, and ethylimidate ester, available for further preparation of imidazolinones.
39
2.2. Synthesis of imidazolinones
2.2.1. Phenylalanine adducts
2.2.1.1. Phenylalanine - Benzimidate Adduct
Both method A and B were tried for the synthesis the phenylalanine -
benzimidate adduct. Using method A, the melting point of recovered product which
was 285-286 C showed that the product was unsaturated product. (Lit. m.p. 284-285





The formation of phenylalanine and benzimidate adduct was the most
successful in method B. It may be the reflux process increase reaction rate compared
with the method A so the yield of the saturated product was increased. The yield was
62.7 %.
The further investigation of the product form method C was performed by
HPLC with chiral column. The product was dissolved in 50/50 hexane/ethanol in
present of 0. 1 % DEA. The HPLC result was shown that there were three major
40
peaks at the retention time at 12.1, 13.3 and 16.2 min. This data suggested that there
were tautomers present in the product mixture.
The 'H NMR was found:
5 7.8 - 7.9, 2H, m; 5 7.4 - 7.6, 3H, m; 5 7.1 - 7.38, 5H, m; 5 4.48 -4.58, 1H, t; 5 3 -
4.5, 2H, m.
2.2.1.2. Phenylalanine - methylimidate Adduct
The methylimidate ethyl ester was so reactive to base that decomposed during
extraction process so it failed to react with the phenylalanine in method A. Another
alternate preparation was used to prepare the amidine chloride instead (Scheme 2-5).
50
In this attempt, acetonitrile was mixed with phenylalanine ethyl ester hydrogen
chloride then dry hydrogen chloride gas was added in one pot reaction. However,
because the phenylalanine ethyl ester hydrogen chloride did not dissolve in solution,








Scheme 2-5 The preparation of amidine.
41
2.2.2. Histidine adducts
Histidine - Benzimidate Adduct
The histidine-benzimidate adduct was prepared by method A. The product
was light yellow oil-like. This adduct was easily oxidized. The TLC result was
shown that there were few by-products. The crystalline product was further purified
by column chromatography (8% methanol/chloroform). The NMR data suggested
that the recovered crystalline product from the column chromatography was an













'HNMR ofhistidine - benzimidate adduct was found:
5 7.4 - 7.58 5H, m; 8 7.78 - 7.85 3H, m.
CI 3 NMR was shown only containing -CH group
43
2.2.3. Tryptophan adducts
Tryptophan - Benzimidate adduct
The tryptophan-benzimidate adduct was prepared by method A. The product
was very oily property and was hard to recover after the reaction was completed.
Even after the product was dried in vacuum oven and recrystallized, it was very
hygroscopic when exposed to air. The TLC data showed that there were some by
products in this preparation. No further investigation was with this adduct. The














2.2.4.1. Valine - Benzimidate Adduct
The first attempt was used method A however only a very small amount of
solid product formed. The white residue was collected by suction filtration and
washed with ethyl ether, and dried in vacuo. TLC showed mostly starting material
present.
The second attempt was carried by the method C and pyridine was used as
base. The melting point of recovered product was started melting at 123 C and
complete at 175 C. This suggested that this was mostly starting materials.
2.2.4.2. Valine - Isopropylimidate Adduct
The first attempt was carried by method B. However, the reaction mixture
was remained clear after three days. This indicated that there was no reaction
occurring.
The method C and diethylamine as base were then applied in this preparation.
The reactants did not completely dissolved in base. The subsequent melting point of
340C showed indicated that the product was the isopropylimidate.
The method C and methylamine as base were also applied in this preparation.
A small amount ofwhite residue formed in the reaction. The white residue was
collected by suction filtration and washed with ethyl ether, and dried
in vacuo. The
melting point of recovered
product was 184C indicating that the product was valine.
45
2.2.4.3. Valine - Ethylimidate Adduct
The method C and diethylamine were applied in this preparation. There was
negligible product collected upon filtration. The product melting point began at 210
C and vaporized at 340 C. This result indicated that this was mostly starting
materials.
2.2.5. Serine Adducts
2.2.5.1. Serine - Benzimidate Adduct
In this attempt, the method C and pyridine as base were applied. TLC of the
recovered product suggested a serine-pyridine complex and benzimidate starting
material.
2.2.5.2. Serine - Isopropylimidate Adduct
The first attempt was carried by method A. However, the reaction mixture
was remained clear after several days. This indicated that there was no reaction
occurred in this preparation.
The second attempt was carried by method C and diethylamine as base. The
melting point turned a dark
color at 160 C. This result indicated that it was still
starting material.
The final attempt of this preparation was applied the method C and
methylamine as base. The reaction turned slight yellow color after few days later.
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When the suspension product was filtered, a yellow oil was recovered. The oily
substance was dried in vacuo, however, the dry crystals were very hygroscopic.
There was no further analysis performed on this adduct.
2.2.5.3. Serine - Ethylimidate Adduct
The method C and diethylamine as base were applied in this preparation.
After collecting the white suspension by filtration, the product was dried in vacuum
oven. The dried crystal was extremely hygroscopic and could not be analyzed.
2.2.6. Proline adducts
2.2.6.1. Proline - Benzimidate Adduct
The method C and pyridine as base were applied in this preparation. The TLC
result indicated that only starting materials were present.
2.2.6.2. Proline - Isopropylimidate Adduct
The method C and methylamine were initially applied. However, the
reactants did not completely dissolved in base. There was negligible product received
and the melting point occured at
340 C, the characteristic of the isopropylimidate
starting material.
The method C and methylamine as base were applied in this preparation. The
reaction has same problem in solubility. The white suspension product was isolated
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by suction filtration and washed with ethyl ether, and dried in vacuo. The recovered
product was very hygroscopic.
The further evidence from both TLC results also indicated that there were
mostly starting materials.
2.2.6.2. Proline - Ethylimidate Adduct
The method C and diethylamine were applied in this preparation. The product
was negligible after collected the white suspension by filtration. The melting point
test of the product could not be performed. TLC of the reaction mixture indicated that
there were mostly starting materials.
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Color white \ white white I white
Physical property solid I solid solid I solid
m.p. 123-124 | 152 C > 340 C
vaporized
| > 340 C
1 vaporized
Note 65.1 g, 89.8%. l hard to
| dissolve.
.01 g, 15.1%. | 8.0 g, 13.7%.
Imidazolones:
I. Treated with base then extracted:
A. A. -Imidate Phe-cj) His-cj> Trp-d) Val-<(>
Color white I yellow dark orange | white
Physical property solid l oil like oil | solid
m.p. a.250; b. 286 !NA NA jNA
IR NA ! NA
NMR NA ;NA
Note 1.72 g, 62.7%. | hygroscopic j 0.6g;26.4%
II. In pyridine/ethanol
A. A. -Imidate Ser-tji Val-<)) Pro-c>
Color orange 1 white | white
Physical property soln 1 solid 1 creamy
stuff
m.p. 162-350vap. j 123-175 | 70
- 360 vap.
IR P- jNA
NMR NA !NA jNA
Note
*: The solution was evaporated to get solid.
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III. Treated with base then extracted:
A. A. -Imidate Val-isop Ser-isop
Color Clear j Clear
Physical property soln | soln
m.p. (C) NA iNA
IR NA !NA
NMR NA ;NA
Note No reaction. I No reaction.
IV. InMethylamine / THF
A. A. -Imidate Ser-isop Val-isop Pro-isop
Color slightly yellow | white j white
Physical property oil like ! solid j solid
m.p. (C) | 184 jNA
IR NA j NA j NA
NMR NA | NA j NA
Note 1 hygroscopic
V. In Diethylamine/THF
A. A. -Imidate Ser-isop Val-isop Pro-isop
Color white | white 1 white
Physical property solid | solid j solid
m.p. (C)
160*
| '340 vap. | '268
IR NA | NA
NMR NA j NA | NA
Note dry crystal is
hygroscopic.
+: turned yellow after in 80C vacuum oven
J: turned to dark color
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VI. In Diethylamine/THF
A. A. -Imidate Ser-et Val-et
Pro-et*
Color white | white j white
Physical property solid | solid j solid
m.p. (-C) NA | 210 -340 vap. j NA
IR 1 NA | NA | NA
NMR NA | NA | NA
Note hygroscopic ! only some residue
j on glassware
c














































































The work presented here is an attempt to synthesize a library of24 chiral
imidazolinones derivatives by condensation of four imidate esters with six different
a-amino acid esters. The following conclusions can be made from this study. First,
imidazolinones can be successfully synthesized by the reaction of imidates with
amino acid derivatives. Further more, the results also indicated that the synthetic
method was most successful with aromatic amino acids and aromatic imidate ethyl
esters. In my experimental work, the compounds which were made from
phenylalanine and histidine with the benzimidate ester were synthesized with the
most success. Aliphatic imidate esters proved to be difficult to prepare and
imidazolinones made from aliphatic amino acid esters were hygroscopic oils and
proved difficult to isolate and purify.
With the aromatic amino acids such as histidine and phenylalanine, the
imidazolinone adducts were found to be crystalline and easy to isolate. However,
characterization of their structures by NMR showed they were fully-conjugated
adducts which may have been a result of rapid
air oxidation or base catalysis. The
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stability of these fully-conjugated structures is likely responsible for the fact that the

















Table 3-1 Fully Saturated imidazolinone adducts
A main goal of this project was to synthesize optically active imidazolinone
derivatives from readily available chiral amino acid esters. With the rapid air
oxidation of the products derived from the aromatic substrates, the optical activity
was easily lost. With nonaromatic substrates,
the likelihood that tautomerization
would occur to give the enolic form (see Section 1.2) could also result in loss of the
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C-4 chiral carbon in these derivatives. The HPLC of the phenylalanine and
benzimidate adduct (see Spectrum 8, p. 84) clearly shows the presence of three
different tautomers for this ring system. Therefore, it is unlikely that optically active
imidazolinone derivatives can be made using this synthetic method without










The work presented in this research was not totally successful in developing a
method of synthesis of chiral imidazolidinone derivatives from a broad selection of
substituted imidates and a-amino acids. However, there remains some synthetic potential
for this condensation reaction that could be further investigated.
This study, in theory, was an excellent application of combinatorial chemistry
where a library of products can be generated by varying substituents on the starting
materials.
In further pursuit of this series of compounds, the reaction of aliphatic amino
acids and imidates should be further examined. As a basis for comparison with the
aromatic amino acids, aliphatic analogs with either electron withdrawing
or donating
groups should be studied. Because of the ability of these ring systems to form stable
radicals, the reactions should be done in the
presence of a suitable radical inhibitor. In
section 1.1, the free radical scavenging ability of
imidazolindinone compounds were
discussed. The highly conjugated nature of the
histidine and tryptophan adducts, in
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particular, may lead to the formation of very stable radicals which may be producing
dimeric byproducts and adversely affecting the yield of the desired monomer.
Another application of this work would be in the alternate synthesis of imazapyr
which was reported in Section 1 .4.2. In Scheme 4-1 is shown a more efficient












Finally, it would be of interest to study the chelating effect of
some of the
imidazolinone derivatives such as those derived from histidine and tryptophan.
Molecular modeling studies could help to design a series
ofmodel compounds of this
ring system to




The IR spectra were run on a Perkin Elmer FT-IR Spectrometer 1 760X. The
NMR spectra for the histidine and benzimidate adducts were performed on a Varian
300 MHz 'H NMR. Melting points were determined on a Thomas-Hoover capellary
melting point apparatus and were uncorrected. Chemicals and solvents were
purchased from Aldrich Chemical Co and J. T. Baker Chemical Co.
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Fig. 5-1 Benzimidate ethyl ester
Benzimidate ethyl ester
Benzonitrile (40 ml, 0.391 moles) and 100 % anhydrous ethanol (38 ml, 0.651 moles)
were placed in a 250 ml round bottle flask. The reaction was cooled to 0 C by an ice
bath, then hydrochloric acid gas was slowly bubbled into the solvent mixture for 1 5
minutes. The flask was capped with a drying tube after the hydrochloric acid gas
addition was completed. The reactants were stirred for 24 hours, at which time the
reaction mixture was completely solidified as a white cake which then washed with
diethyl ether. The product was separated by suction filtration and washed with






Fig. 5-2 Methylimidate ethyl ester
Methylimidate ethyl ester
A. Acetonitrile (20.6 ml, 0.394 moles) and 100 % anhydrous ethanol (36.5 ml, 0.625
moles) were placed in a 250 ml round bottle flask. The reaction was cooled to 0 C by
an bath, then hydrochloric acid gas was slowly bubbled into the solvent mixture for
15 minutes. The flask was capped with a drying tube after the hydrochloric acid gas
addition was completed. The white solid was precipitated as soon as hydrochloric
acid gas was added. The reactants were kept stirring for 2 days. The product was
separated by suction filtration. Washed with diethyl ether, dried in vacuo at 100 C 1
hour to give 10.75 g, 20.9%. The melting point is 152 C
B. Methyl Amidine
Acetonitrile (20.6 ml, 394 mmol), L-Phenylalanine ethyl ester hydrochloride (2.5 lg,
110 mmol) and CH2C12 (25 ml) was placed in a 250 ml round bottle flask.
Hydrochloric acid gas was slowly bubbled into the solvent mixture for 1 hrs. The
solution was turn clear after hydrochloric acid gas was added for 1 0 minutes. The
flask was capped with the drying tube after hydrochloric acid gas addition was
completed. The reactants were kept stirring for 24 hours. The product was separated
by suction filtration. Washed with diethyl ether, dried in vacuo at 100C 1 hour to





Fig. 5-3 Ethylimidate ethyl ester
Ethylimidate ethyl ester
Propionitrile (27.6 ml, 0.386 moles) and 100 % anhydrous ethanol (36.0 ml, 0.617
moles) was placed in a 250 ml round bottle flask. The reaction was cooled to 0 C by
an bath, then hydrochloric acid gas was slowly bubbled into the solvent mixture for
1 5 minutes. The flask was capped with a drying tube after the hydrochloric acid gas
addition was completed. The reactants were stirred for 3 days, at which time the
reaction mixture was partially solidified as a white cake which was separated by
suction filtration. The solid was washed with diethyl ether and dried in vacuo at 80






Fig. 5-4 Isopropylimidate ethyl ester
Isopropylimidate ethyl ester
Isobutyronitrile (35.0 ml, 0.385 moles) and 100 % anhydrous ethanol (36.5 ml, 0.625
moles) were placed in a 250 ml round bottle flask. The reaction was cooled to 0 C by
an bath, then hydrochloric acid gas was slowly bubbled into the solvent mixture for
1 5 minutes. The flask was capped with a drying tube after the hydrochloric acid gas
addition was completed. The reactants were stirred for 7 days. The reaction mixture
was slowly solidified as a white solid which was then washed with diethyl ether. The
product was separated by suction filtration, washed with diethyl ether and dried in
vacuo at 80 C for 2 hour to give 8.0 g, 13.7%. The melting point was over 340 C.
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5.2. Synthesis of Imidazolinones





Fig. 5-5 General Structure of amino acids with benzimidate ethyl ester adduct
2-phenyl-4-isopropyl-imidazolin-5-one
(Valine - Benzimidate Adduct)
A. L-Valine methyl ester hydrochloride (1.84g, 1 1.22mmol.) was suspended in
CH2C12 (15 ml) and basified with 3N NaOH until basic to pH paper. The aqueous
solution was extracted three times with methlene chloride CH2C12 (15-20 ml), and the
organic layers combined. The same treatment was used with benzimidate ethyl ester
hydrochloride (2.13g, 1 1.5 mmol.). The two organic extracts were combined and
dried with anhydrous magnesium sulfate (MgS04). The magnesium sulfate was
removed by the simple filtration and the filtrate collected in a 250 ml round bottle
flask. The filtrate was stirred for at least 36 hours, then concentrated to give a white
solid suspension. The solid was filtrated and washed with ethyl ether. The white
solid was dried in vacuo at 100 C for 1 hour to give 0.6 g, 26.4 %.
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B. L-Valine methyl ester hydrochloride (0.41g, 2.5mmol.) was suspended in 100 %
anhydrous ethanol (10 ml) and basified with pyridine (0.4g, 5 mmol.). The reaction
was stirred until all solids were dissolved then the benzimidate ethyl ester
hydrochloride (0.47g, 2.5 mmol.) was added. The mixture was refluxed for 20 hours.
The white solid product which formed was separated by suction filtration and dried in
vacuo at 100 C for 1 hour. The melting point range was 123 C (softened) to 175 C
(melted).
Proline - Benzimidate adduct
L-Proline methyl ester hydrochloride (5g, 30.2 mmol.) was suspended in 100 %
anhydrous ethanol (120 ml) and basified with pyridine (4.5 ml, 55.8 mmol.). The
reaction was stirred until all solids were dissolved then the benzimidate ethyl ester
hydrochloride (5.6g, 30.3 mmol.) was added. The mixture was refluxed for 20 hours.
The white solid product which formed was separated by suction filtration and dried in




(Serine - Benzimidate Adduct)
L-Serine methyl ester hydrochloride (7.78g, 50 mmol.) was suspended in 100 %
anhydrous ethanol (150 ml) and basified with pyridine (1 1.86g, 149 mmol.). The
reaction was stirred until all solid were dissolved then the benzimidate ethyl ester
hydrochloride (9.30g, 50.2 mmol.) was added. After refluxing for 24 hours, the color
of solution turned orange and had a white solid suspension. The white solid product
was separated by suction filtration and the filtrate was further concentrated. The
combined white solids were dried in vacuo at 1 00 C 1 hour. The melting point of
white product was began to melt at 162C and turned dark around 350 C. The range
ofmelting point suggested that the white product was possible two materials. A
column chromatography separation was attempted but gave no separation.
2-phenyl-4-benzyl-imidazolin-5-one
(Phenylalanine - Benzimidate Adduct)
A. L-Phenylalanine ethyl ester hydrochloride (4.08g, 17.7 mmol.) was suspended in
CH2C12 (15 ml) and basified with 3N NaOH
until basic to pH paper. The aqueous
solution was extracted three times with methylene chloride CH2C12 (15-20 ml) and
the organic layers combined. The same treatment was used
with benzimidate ethyl
ester hydrochloride (5.04 g, 19.5 mmol.). These two
organic extracts were combined
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and dried with anhydrous magnesium sulfate (MgS04). A simple filtration was used
to collected the filtrate which was stirred for two days. Upon concentration, a solid
was formed which was washed with diethyl ether and dried in vacuo at 100C for 1
hour to give pale yellow crystals 0.4 g, 9%. The melting point was found to be 285
-
286C
B. L-Phenylalanine ethyl ester hydrochloride (2.52g, 10.9 mmol.) was suspended in
CH2C12 (15 ml) and basified with 3N NaOH until basic to pH paper. The aqueous
solution was extracted three times with methylene chloride CH2C12 (15-20 ml) and
the organic layers combined. The same treatment was used with benzimidate ethyl
ester hydrochloride (2.13g, 1 1.5 mmol.). The two organic extracts were combined
and dried with anhydrous magnesium sulfate (MgS04). The magnesium sulfate was
removed by the simple filtration and the filtrate collected in a 250 ml round bottle
flask. The filtrate was refluxed for 10 hours and stirred for another 12 hours. The
imidazolinone precipitated out as a white solid. The solid was filtrated and washed
with ethyl ether and dried in vacuo at 100 C for 1 hour to give 1 .72 g, 62.7%.
2-phenyl-4-(imidazoIy-4-methyl)-imidazolin-5-one
(Histidine - Benzimidate Adduct)
L-Histidine methyl ester hydrochloride (2.52g, 10.4 mmol.) was suspended in CH2C12
(15 ml) and basified with 3N
NaOH until basic to pH paper. The aqueous solution
was extracted three times with methylene chloride CH2C12 (15-20 ml) and the organic
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layers combined. The same treatment was used with benzimidate ethyl ester
hydrochloride (2.13g, 1 1.5 mmol.). The two organic extracts were combined and
dried with anhydrous magnesium sulfate (MgS04). The magnesium sulfate was
removed by the simple filtration and the filtrate collected in a 250 ml round bottle
flask. Concentrated the filtrate and stirred for two days. The yellow viscous solution
was formed. A column chromatography was attempted to separate the pure yellow
product. The separated pure product was sent to do 'H NMR.
2-phenyl-4-(indol-3-yI-methyl)-imidazolin-5-one
(Tryptophan - Benzimidate Adduct)
L-Tryptophan ethyl ester hydrochloride (2.74g, 10.7 mmol.) was suspended in CH2C12
(15ml) and basified with 3N NaOH until basic to pH paper. The aqueous solution
was extracted three times with methylene chloride CH2C12 (15 -20 ml) and the organic
layers combined. The same treatment was used with benzimidate ethyl ester
hydrochloride (2.13g, 1 1.5 mmol.). The two organic extracts were combined and
dried with anhydrous magnesium sulfate (MgS04). The magnesium sulfate was
removed by the simple filtration and the filtrate collected in a 250 ml round bottle
flask. The filtrate was stirred for at least 36 hours, then concentrated to give the dark
orange precipitated. The product was filtrated with diethyl ether. The dark orange
product was dried in vacuo. The dry crystal was very hygroscopic and the melting
point could not be measured.
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Fig. 5-6 General Structure of amino acids with isopropylimidate ethyl ester adduct
2-isopropal -4-isopropal-imidazoIin-5-one
(Valine - Isopropylimidate Adduct)
A. L-Valine methyl ester hydrochloride (0.835g, 4.98 mmol.) and isopropylimidate
ethyl ester hydrochloride (0.76g, 5.03 mmol.) were suspended in THF (10 ml) and
basified with diethylamine (1.2g, 16.4 mmol.). After stirring for 2 days, the solution
still had white suspension. The white solid product was separated by suction
filtration and washed with diethyl ether. The white solid was dried in vacuo at 80 C
1 hour. The white product melted about 340 C, with decomposition.
B. L-Valine methyl ester hydrochloride (0.835g, 4.98 mmol.) and isopropylimidate
ethyl ester hydrochloride (0.76g, 5.03 mmol.) were suspended in THF (10 ml) and
basified with 2.0M methylamine in THF (7.5ml, 15 mmol.) After stirring for 4 days,
a white residue formed on the surface of glassware. The white solid product was
separated by suction filtration and washed with diethyl
ether. The white solid was
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dried in vacuo at 80 C for 1 hour to give 1.35g, 161.2% . The melting point ofwhite
product was about 183-184 C, with decomposition.
Proline - Isopropylimidate Adduct
A. L-Proline methyl ester hydrochloride (0.82g, 4.95 mmol.) and isopropylimidate
ethyl ester hydrochloride (0.79g, 5.229 mmol.) were suspended in THF (10 ml) and
basified with diethylamine (1
.2g,
16.4 mmol.). After stirring for 2 days, the solution
still had a white suspension. The white solid product was separated by suction
filtration and washed with diethyl ether. The white solid was dried in vacuo at 100 C
for 1 hour. The melting point ofwhite product was about 268 C, with
decomposition.
B. L-Proline methyl ester hydrochloride (0.8g, 4.83 mmol.) and isopropylimidate
ethyl ester hydrochloride (0.8g, 5.29 mmol.) were suspended and basified with 2.0M
methylamine in THF (10ml, 20 mmol.). After stirring for 2 days, the solution still
had a white suspension. The white solid product was separated by suction filtration
and washed with diethyl ether. The white solid was dried in vacuo at 100 C for 1
hour to give 1.3g of a hydroscopic solid whose melting point could not be taken.
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2-isopropal-4-(l-hydroxo-methlene)-imidazolin-5-one
(Serine - Isopropylimidate Adduct)
A. L-Serine methyl ester hydrochloride (1.55g, 9.96 mmol.) and isopropylimidate
ethyl ester hydrochloride (1.56g, 10.3 mmol.) were suspended in THF (20 ml) and
basified with diethylamine (2.4g, 32.8 mmol.). After stirring for 2 days, the solution
still contained white suspension. The white solid product was separated by suction
filtration and washed with diethyl ether. The white solid was dried in vacuo at 100 C
for 1 hour. The melting point ofwhite product was about 160 C, with decoposition.
B. L-Serine methyl ester hydrochloride (1.55g, 9.96 mmol.) and isopropylimidate
ethyl ester hydrochloride (1.6g, 10.6 mmol.) were suspended in THF (20 ml) and
basified with 2.0M methylamine in THF (20ml, 40 mmol.). After stirring for 4 days,
the mixture was mostly homogeneous. The mixture was then separated by suction
filtration and washed with diethyl ether. The solid formed was very sticky after
drying in an 80 C oven overnight and turned dark yellow. The filtrate was an oil like
solution with an orange color.
70







Fig. 5-7 General Structure of amino acids with ethylimidate ethyl ester adduct
2-ethyl -4-isopropal-imidazolin-5-one (Valine - Ethylimidate Adduct)
L-Valine methyl ester hydrochloride (1.67g, 9.96 mmol.) and ethylimidate ethyl ester
hydrochloride (1.38g, 10.1 mmol.) were suspended in CH2C12 (20 ml) and basified
with diethylamine (2.43g, 33.2 mmol.). After stirring for 2 days, the solution still had
white suspension. The white solid product was separated by suction filtration and
washed with diethyl ether. The recovered product was negligible. The white solid
was dried in vacuo at 80 C 1 hour. The melting point ofwhite product was started at
210 C and vaporized around 340 C.
2-ethyl -4-(l-hydroxo-methlene)-imidazolin-5-one
(Serine - Ethylimidate Adduct)
L-Serine methyl ester hydrochloride (1.55g, 9.96 mmol.) and ethylimidate ethyl ester
hydrochloride (1.40g, 10.2 mmol.) wwere suspended in THF (20 ml) and basified
with diethylamine (2.7g, 36.9 mmol.). After stirring for 5 days, the solution turn light
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yellow but still had a white suspension. The white solid product was separated by
suction filtration. The white solid was dried in vacuo at 100 C overnight. The
product was very hygroscopic and the melting point could not be measured.
Proline - Ethylimidate adduct
L-Proline methyl ester hydrochloride (2.0 lg, 12.13 mmol.) and ethylimidate ethyl
ester hydrochloride (3.87g, 28.2 mmol.) were suspended in THF (10 ml) and basified
with 2.0M methylamine in THF (16 ml, 32 mmol.). After stirring for 2 days, the
solution still had white suspension. The white solid product was separated by suction
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